期刊文献+

喹喔啉-三唑衍生物的设计与合成及其抗肿瘤活性 被引量:3

Design,Synthesis and Antitumor Activities of Quinoxaline-triazole Derivatives
原文传递
导出
摘要 喹喔啉和1,2,3-三唑都是具有广泛生物活性的杂环结构母体。本文基于药物设计的拼合原理,以简单易得的邻苯二胺、苯乙炔及有机叠氮为原料,通过三组分"两步一锅法"将喹喔啉和1,2,3-三唑活性亚结构进行拼接,合成了一系列共14个新型喹喔啉-三唑衍生物(3a^3n)。该法操作简单,无需分离中间体,两步总产率52.6%~78.4%。合成的目标化合物结构经~1H NMR、^(13)C NMR和HRMS确证。初步体外抗肿瘤活性测试表明,合成的目标化合物具有一定的抗肿瘤活性。 Quinoxalines and 1,2,3-triazoles are both skeletons with wide biological activities. In this paper,based on the combination principles of drug design,starting from o-phenylene diamine,phenylacetylene and organic azides,a series of new quinoxaline-triazole derivatives( 3 a ~ 3 n) were synthesized by three-component "two step one-pot"reactions. This pr℃edure had the advantages of operation simplicity and without isolating intermediates with isolated yields in the range of 52. 6% ~ 78. 4%. The structures of target compounds were characterized by ^1 H NMR,^13 C NMR and HRMS. The result of preliminary bioassay shows that the synthesized target compounds possess antitumor activities to some extent.
作者 李泳坤 李玖零 王恒山 王迎春 Li Yongkun;Li Jiuling;Wang Hengshan;Wang Yingchun(College of Chemistry and Chemical Engineering,Hunan Engineering Laboratory for Analyse and Drugs Development of Ethnomedicine in Wuling Mountains,Jishou University,Jishou 416000;State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources,School of Chemistry and Pharmaceutical Sciences of Guangxi Normal University,Guilin 541004)
出处 《化学通报》 CAS CSCD 北大核心 2018年第9期847-852,共6页 Chemistry
基金 国家自然科学基金项目(21762017) 湖南省自然科学基金项目(2016JJ4075) 湖南省教育厅自然科学基金项目(16B211)资助
关键词 喹喔啉 1 2 3-三唑 合成 抗肿瘤活性 Quinoxaline 1 2 3-Trizoles Synthesis Anti-tumor activity
  • 相关文献

参考文献3

二级参考文献26

  • 1曾仲武,姜雅君.新稻田除草剂Metamifop[J].农药,2004,43(7):327-328. 被引量:23
  • 2李斌,相东,崔东亮,等.具有除草活性的α,β和β,γ不饱和羧酸酯类化合物:CN,1626526[P].2003-12-12. 被引量:1
  • 3REDDY M V R, PITRE V S, BHATTACHARYA I, et al. Zeolite(H-ZSM5) Catalysed Regioselective Isomerisation of Glycidic Esters to α-Hydroxy-β, γ-unsaturated Esters[J]. Synlett, 1996, (3): 241-242. 被引量:1
  • 4张文正.人人健康,2012,23:24. 被引量:1
  • 5N Bucher, C D Britten. Br. J. Cancer, 2008,98(3) :523 - 528. 被引量:1
  • 6Z Chen, Z Xiao, J Chen. Mol. Cancer Ther. , 2003, 2(6) : 543 - 548. 被引量:1
  • 7S R Musk, G G Steel. Int. J. Radiat. Biol. , 1990, 57(6) : 1105 - 1112. 被引量:1
  • 8Y Luo, J D Leverson. Expert Rev. Anticancer Ther. , 2005, 5(2) : 333 -342. 被引量:1
  • 9K L Arrington, V Y Dudkin. Chem. Med. Chem. , 2007, 2 (11): 1571 -1585. 被引量:1
  • 10Y Pan, KHRen, H W Heetal. Cancer Biol. Ther. , 2009, 8(16) : 1559 - 1566. 被引量:1

共引文献15

同被引文献6

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部